Company Profile:
Industry: BioIT
Founded: 06/2006
Mission: To provide revolutionary, fast, comprehensive automated Natural Language Processing based tools for accurately extract information from technical literature
Management: The Parseon team has over 55 years of pharmaceutical and biotechnology experience, as well as over 10 years of experience in software design and artificial intelligence.
Lynne H Parker, PhD, President
R. Polsky-Newman, PhD, CBO
Marc C Hadfield, CTO
Contact:
Rosemary Polsky - Newman, PhD
Phone: 212 627 - 9175
Fax: 646 254 - 0322
info@parseoninc.com
rpolsky-newman@parseoninc.com
|
|
Parseon is a small, privately held company, whose next generation technology will revolutionize the way researchers access information from literature.
The company’s products address the information needs of the $51.3B Pharmaceutical Research Industry including Knowledge Extraction from publications in the Technical & Medical Information Market ($25.5B) and the Bioinformatics Market ($3B).
The company is very interested in growing more quickly than its current resources allow, and is eager to speak to potential investors. If you are a potential investor, or if you would just like to find out more about Parseon, its products, its technology, its business plan, and/or its management, please contact us at info@parseoninc.com
Individuals or companies who are interested in purchasing product that incorporate the Parseon technology should also contact Parseon at info@parseoninc.com for information . |